Norén, G. N., R. Sundberg, A. Bate, and I. R. Edwards. 2008. A statistical methodology for drug-drug interaction surveillance. Statistics in Medicine 27(16):3057-3070.

Pittman, P. R. 2002. Aluminum-containing vaccine associated adverse events: Role of route of administration and gender. Vaccine 20(Suppl 3):S48-S50.

Price, C. S., W. W. Thompson, B. Goodson, E. S. Weintraub, L. A. Croen, V. L. Hinrichsen, M. Marcy, A. Robertson, E. Eriksen, E. Lewis, P. Bernal, D. Shay, R. L. Davis, and F. DeStefano. 2010. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 126(4):656-664.

Rothman, A. L. 2011. Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms. Nature Reviews Immunology 11(8):532-543.

Rothman, K. J., Y. Young-Xu, and F. Arellano. 2006. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. The Journal of Infectious Diseases 193(6):898.

Rowhani-Rahbar, A., N. Lewis, B. Fireman, R. Baxter, N. Klein, and other VSD colleagues. 2012. Effect of age on the risk of seizure following immunization with measles-containing vaccines: VSD study 233—preliminary results. Paper presented at Vaccine Safety Datalink Annual Meeting, Denver, CO.

Sears, R. 2007. The vaccine book: Making the right decision for your child, 1st ed. New York: Little, Brown.

Thakrar, B. T., S. B. Grundschober, and L. Doessegger. 2007. Detecting signals of drug-drug interactions in a spontaneous reports database. The British Journal of Clinical Pharmacology 64(4):489-495.

Tse, A., H. F. Tseng, S. K. Greene, C. Vellozzi, G. M. Lee, and the VSD Rapid Cycle Analysis Influenza Working Group. 2012. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink project, 2010-2011. Vaccine 30(11):2024-2031.

Veirum, J. E., M. Sodemann, S. Biai, M. Jakobsen, M. L. Garly, K. Hedegaard, H. Jensen, and P. Aaby. 2005. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 23(9):1197-1204.

Yih, W. K., M. Kulldorff, B. H. Fireman, I. M. Shui, E. M. Lewis, N. P. Klein, J. Baggs, E. S. Weintraub, E. A. Belongia, A. Naleway, J. Gee, R. Platt, and T. A. Lieu. 2011. Active surveillance for adverse events: The experience of the Vaccine Safety Datalink project. Pediatrics 127(Suppl 1):S54-S64.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement